Multiple Myeloma Awareness Month: When the Doctor Becomes the Caregiver

Read More

CTLA4 blockade broadens the peripheral T-cell receptor repertoire

Robert et al.
Clinical Cancer Research
Papers
May 2014
Authors and Affiliates
Lidia Robert,1 Jennifer Tsoi,2 Xiaoyan Wang,1,3 Ryan Emerson,7,8 Blanca Homet,1,9 Thinle Chodon,1 Stephen Mok,1,2Rong Rong Huang,4 Alistair J. Cochran,4 Begonya Comin-Anduix,5,6 Richard C. Koya,4,6 Thomas G. Graeber,2,6 Harlan Robins,7,8 and Antoni Ribas1,2,4,6 1Department of Medicine (Division of Hematology-Oncology), University of California Los Angeles (UCLA), 2Department of Molecular and Medical Pharmacology, University of California Los Angeles (UCLA), 3Department of Medicine (Statistics core), University of California Los Angeles (UCLA), 4Department of Pathology and Laboratory Medicine, University of California Los Angeles (UCLA), 5Department of Surgery (Division of Surgical-Oncology), University of California Los Angeles (UCLA), 6Jonsson Comprehensive Cancer Center (JCCC), University of California Los Angeles (UCLA), 7Fred Hutchinson Cancer Research Center, Seattle, WA, 8Adaptive Biotechnologies, Seattle, WA, 9Instituto de Salud Carlos III, Madrid, Spain